Latest News – PSNC Main site Pharmaceutical Services Negotiating Committee

  • PQS: Support available for the dementia-friendly environment checklist and action plan
    Posted by taylorr on 17th October 2019 at 10:34 am

    Community pharmacy contractors may now like to consider completing the dementia-friendly environment checklist and action plan to meet the quality criterion, if they have not already done so. To meet the dementia-friendly environment checklist quality criterion, contractors are required to have completed, on the day of the declaration, a specified dementia-friendly environment checklist and […]

  • Class 4 MHRA drug alert – Xonvea 10 mg/10 mg gastro-resistant tablets (Alliance Pharmaceuticals Limited)
    Posted by Mitesh on 16th October 2019 at 2:29 pm

    Class 4 MHRA drug alert – Xonvea 10 mg/10 mg gastro-resistant tablets (Alliance Pharmaceuticals Limited) Drug alert number: EL (19)A/26 Date issued: 16 October 2019 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 pharmacy level caution in use for: Xonvea 10 mg/10 mg gastro-resistant tablets (Alliance Pharmaceuticals Limited) Alliance Pharmaceuticals... […]

  • PQS: Directory of Services (DoS) update
    Posted by taylorr on 16th October 2019 at 10:04 am

    We have been made aware that, due to the NHS Urgent Medicine Supply Advanced Service (NUMSAS) and the Digital Minor Illness Referral Service (DMIRS) finishing on 28th October 2019 and the Community Pharmacist Consultation Service (CPCS) starting on 29th October 2019, that this has caused some confusion for community pharmacy contractors when updating their DoS... […]

  • Contractor Notice: Class 4 Drug Alert For Information / Action Rifadin (Rifampicin) 150mg Capsules
    Posted by hackettg on 16th October 2019 at 9:27 am

    Class 4 MHRA drug alert – Rifadin (rifampicin) 150mg Capsules (Aventis Pharma Limited t/a Sanofi) Drug alert number: EL (19)A/25 Date issued: 16 October 2019 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 pharmacy level caution in use for: Rifadin (rifampicin) 150mg Capsules – PL 04425/5915R Aventis Pharma Limited t/a... […]

  • Supply Disruption Alert – Ranitidine all oral formulations
    Posted by Mitesh on 15th October 2019 at 4:04 pm

    All oral formulations of Ranitidine are anticipated to be out of stock, with no date for resupply until further notice. The following oral presentations of Ranitidine are affected: Ranitidine 75mg, 150mg and 300mg tablets Ranitidine 150mg and 300mg effervescent tablets Ranitidine 150mg/5ml oral solution Ranitidine 75mg/5ml oral solution The Supply Disruption Alert (SDA/2019/005) issued by […]

  • PSNC responds to government consultation on prevention
    Posted by fergusonj on 15th October 2019 at 3:31 pm

    PSNC has outlined how community pharmacies can contribute to the prevention agenda in its response to a government consultation. Earlier this year, the Government set out a green paper, Advancing our health: prevention in the 2020s, outlining policy ideas to help prevent ill-health. The paper then opened to consultation in the form of an online... […]

  • Contractor Notice: SSP Endorsement Errors
    Posted by Mitesh on 14th October 2019 at 2:26 pm

    Following the announcement of the first Serious Shortage Protocols (SSPs) issued on 3rd October 2019 for Fluoxetine capsules, PSNC has been working with NHS Business Services Authority (NHSBSA) to understand if claims are being submitted in accordance with SSP endorsement guidance. During the month of October, NHSBSA has received a number of EPS messages which... […]

  • Self Care Week 2019
    Posted by alkharsanz on 14th October 2019 at 8:05 am

    Self Care Week, which is an annual national awareness week that focuses on providing support for self care across communities and families, will be running again this year on 18-24th November 2019. The campaign aims to provide people-facing organisations such as community pharmacies with a focus to hold a targeted campaign to support people to take care... […]

  • Final CPCS service spec published
    Posted by buxtona on 13th October 2019 at 11:49 am

    Following its passage through the NHS England and NHS Improvement (NHSE&I) internal governance process, the final version of the Community Pharmacist Consultation Service (CPCS) service specification has now been published. CPCS service specification Prior to this final version of the service specification being published, a draft version was published on the NHSBSA website. A small... […]

  • New guidance on physical activity issued by UK Chief Medical Officers
    Posted by Helen on 12th October 2019 at 3:03 pm

    Last month, the UK Chief Medical Officers published updated guidance on the importance of physical activity for supporting overall health. The report, an update from the original guidance issued in 2011, reinforces previous guidelines on building strength, balance and cardiovascular fitness, and now includes additional information on activity during and post-pregnancy, and for disabled adults.... […]